|
|
|
501-1,000 employees
View all
|
|
Fundraising
|
|
200 Vesey St, 28th Floor, New York, New York 10281, US
|
|
JDRF is the only global organization with a strategic research plan to end type 1 diabetes (T1D). Our plan ensures that there will be an ongoing stream of life-changing therapies moving from development through to commercialization that lessen the impact of T1D. We want to keep people with T1D healthy and safe today until we reach our ultimate goal of a cure and universal prevention of T1D.
JDRF collaborates with a wide spectrum of partners at every stage of the drug delivery pipeline and is the only organization with the scientific resources, regulatory influence, and a strategic plan to deliver a world without T1D. JDRF’s influence and leadership extends beyond funding research. We strategically partner with industry, governments, foundations, academia and clinicians, because curing T1D is a global, coordinated effort with JDRF at the center.
For more information, please visit www.jdrf.org.
|
James Mcdonald is the CEO of JDRF International. To contact James Mcdonald email at [email protected] or [email protected].
The decision makers in JDRF International are Aaron Kowalski, Amy Pricer Montalto, Jason Fronek, etc. Click to Find JDRF International decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.